EPHX2 and metabolic dysfunction-associated steatohepatitis: Although recent reports indicate that sEH inhibition may attenuate the development of insulin resistance and hepatic steatosis in response to a high-fat diet [41], [42], the functional contribution of the CYP epoxygenase pathway to the regulation of NAFLD/NASH-associated hepatic inflammation and injury had not been evaluated.